Los Angeles Capital Management LLC Atea Pharmaceuticals, Inc. Transaction History

Los Angeles Capital Management LLC

  • $24.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023
SELL
$4.35 - $6.17 $9,135 - $12,957
-2,100 Reduced 1.19%
175,048 $841,000
Q3 2022

Nov 02, 2022
SELL
$5.49 - $8.79 $133,549 - $213,825
-24,326 Reduced 12.07%
177,148 $1.01 Million
Q2 2022

Aug 05, 2022
SELL
$5.33 - $8.18 $162,303 - $249,089
-30,451 Reduced 13.13%
201,474 $1.43 Million
Q1 2022

May 06, 2022
BUY
$5.5 - $9.19 $1.28 Million - $2.13 Million
231,925 New
231,925 $1.67 Million

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $270M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email